Navigation Links
CardioGenics Holdings Inc. Featured in Medical Device Daily
Date:11/13/2009

MISSISSAUGA, Ontario, Nov. 13 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), a developer of technology and products targeting the immunoassay segment of the IVD testing market, was featured in Medical Device Daily's November 12, 2009 edition.

The article by Amanda Petersen, titled "CardioGenics aims to offer faster heart attack diagnosis," shares insights from CardioGenics CEO Yahia Gawad, MD regarding the company's point-of-care (POC) cardiac diagnostic technology. This technology includes the QL Care® Analyzer, designed to provide a more rapid diagnosis of heart attacks, to meet the guidelines established by the American Heart Association and the American College of Cardiology. It also includes the company's highly reflective paramagnetic beads, intended as a more light-sensitive alternative to beads currently used in 90% of medical lab analyzers.

The Medical Device Daily piece explains, "Speed of diagnosis is important when physicians are dealing with possible heart attack patients because they need to decide quickly how they are going to treat the patient, if they are going to be aggressive or use a more conservative therapy." In the article, Dr. Gawad notes, "For every hour you delay treating the patient it costs three lives, so the time is extremely important." Equally crucial, the article reports Gawad as saying, is the need to base that treatment decision on a sound diagnosis. The use of this POC test could reduce healthcare costs and offer faster diagnosis, Gawad states in the article.

The article goes on to describe the single-use cartridge QL Care® Analyzer, which CardioGenics states as offering a "quantum leap" in existing POC immunoassay technology: "In just six steps, the QL Care® Analyzer provides printed medical lab quality results in less than fifteen minutes." Gawad is reported in the article as noting that the company's initial target for the device is emergency rooms, chest pain clinics, and cardiac care units, but could be used in ambulances as well. CardioGenics is also reported as anticipating that the device cartridge can be ultimately adapted to run any number of immunoassay tests.

The article goes on to describe CardioGenics' other lead product, silver-coated magnetic beads that are more reflective and capable of delivering sensitivity five-to-ten times higher than competitive products in the chemiluminescence testing space.

The Medical Device Daily article is available online at http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=68998.

About CardioGenics Holdings Inc.

CardioGenics is dedicated to developing more sensitive diagnostic test products for the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective "to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies." CardioGenics' operating philosophy is that "better diagnosis enhances the healthcare professionals' ability to provide better patient management which saves lives and reduces healthcare costs." Fulfilling unmet clinical testing needs is the driving force behind CardioGenics' innovations. Its current products include the QL Care Analyzer ("QLCA"), a state-of-the-art proprietary point of care ("POC") immunoanalyzer; a series of immunoassay tests to detect cardiac markers; and a proprietary method for improving the light collection from paramagnetic beads ("Beads"). You can learn more about CardioGenics at (cardiogenics.com).

SOURCE CardioGenics Holdings Inc.


'/>"/>
SOURCE CardioGenics Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioGenics Holdings Inc. Announces Letter to Shareholders
2. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
3. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
4. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
5. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
6. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
7. Select Medical Holdings Corporation Announces Exercise of Underwriters Option to Purchase Additional Shares
8. Lincare Holdings Inc. Extends Terms of Employment Agreements with Executive Officers
9. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
10. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... manufacturing solutions for cell and advanced therapies , ... the French biopharmaceutical company developing "tumor starvation" treatments ... unmet medical needs. Under the agreement, Invetech will ... products based on Erytech,s proprietary ERYCAPS technology platform, ...
(Date:1/18/2017)... January 18, 2017 After the recent ... the use of cannabis both for medical and recreational purposes ... Americans open to the use of cannabis, but the focus ... to Arcview Market Research, the North American legal cannabis market ... the previous year. The research projects sales will grow at ...
(Date:1/17/2017)... 2017 North America Insulin Delivery Market Outlook ... America Insulin Delivery Market Outlook to 2022", provides key ... The report provides value, in millions of US dollars, ... segments - Insulin Pens, Insulin Pumps, Insulin Syringes and ... company shares and distribution shares data for each of ...
Breaking Medicine Technology:
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... Delaware farmer ... in St. Louis, Missouri. , Dickerson, of Laurel, farms about a thousand acres of ... beans, yellow squash on contract and pumpkins and other vegetables for the fresh market. ...
(Date:1/18/2017)... ... January 18, 2017 , ... Visually learn facts and tips ... antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are common conditions that occur ... to explain the seven types of hyperhidrosis. This visual creates awareness about the ...
(Date:1/18/2017)... USA; and SHANGHAI, China – , ... ... -- Global public health organization NSF International has certified the ... to NSF/ANSI 53: Drinking Water Treatment Units – Health Effects, ... certification verifies that MicroCeramics’ NanoNose Pitcher Filter System filters the ...
(Date:1/18/2017)... ... , ... The V Foundation for Cancer Research, a top-rated cancer research charity, ... team, to compete in the Boston Marathon on April 17. From first-time participants ... annual marathon to join Team V and support the Foundation’s mission to declare victory ...
(Date:1/18/2017)... Fresno, CA (PRWEB) , ... January 18, 2017 ... ... is pleased to announce that their Vice President of Franchise Development, Paula Turner ... , This award-winning business program, which features the insights of top business leaders ...
Breaking Medicine News(10 mins):